AWS GraphRAG deployment cuts drug research cycles by 87%
A latest AWS GraphRAG deployment diminished drug research and growth cycles in pharmaceutical environments by 87 p.c. This acceleration is achieved by integrating beforehand separated proprietary databases right into a unified and queryable data graph. Historically, preliminary information gathering and screening phases took over six months per iteration, yielding a low 5 p.c success fee….
